Cloud Banner

Medical Devices

Image

Global Liquid Biopsy Market – Industry Trends and Forecast to 2031

  • Medical Devices
  • Published Report
  • Dec 2023
  • Global
  • 350 Pages
  • No of Tables: 1246
  • No of Figures: 60

Global Liquid Biopsy Market, By Product (Instruments, Consumables & Accessories, and Services & Software), Biomarker Type (Circulating Tumor Cells (CTCS), Circulating Cell-Free DNA (CFDNA), Cell-free RNA, Extracellular Vesicles, Exosomes, and Others), Sample Type (Blood Sample Based, Urine Sample Based, Saliva & Other Tissue Fluid Sample-Based, Fecal Based Sampling, and Others), Analytical Type (Molecular, Proteomics, and Histology/Imaging), Application Type (Cancer Applications and Non-Cancer Applications), Clinical Application (Routine Screening, Patient Work-Up, Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Others), Technology (Multi-Gene Parallel Analysis, and Single-Gene Analysis), End User (Hospitals, Reference Laboratories, Diagnostic Centers, Research Centers & Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributor, and Others) - Industry Trends and Forecast to 2031.

Liquid Biopsy Market

Liquid Biopsy Market Analysis and Insights

The increasing awareness of advanced diagnostic technology globally has enhanced the demand for the market. The rising healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increase in improved advancement of processes and techniques also contributes to the rising demand for liquid biopsy.

Liquid Biopsy MarketLiquid Biopsy Market

The global liquid biopsy market is growing in the forecast year due to the rise in market players and the availability of advanced services. Manufacturers are engaged in the developmental activity for launching novel services in the market. The increasing development in the field of advanced healthcare techniques is further boosting market growth. However, difficulties such as the lack of standardized protocols and the lack of skilled professionals might hamper the growth of the global liquid biopsy market in the forecast period.

The global liquid biopsy market is expected to gain market growth in the forecast period of 2024 to 2031. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.8% in the forecast period of 2024 to 2031 and is expected to reach USD 7,429.32 Million by 2031 from USD 2,309.91 Million in 2023.

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volume in Units, Prices in USD

Segments Covered

Product (Instruments, Consumables & Accessories, and Services & Software), Biomarker Type (Circulating Tumor Cells (CTCS), Circulating Cell-Free DNA (CFDNA), Cell-free RNA, Extracellular Vesicles, Exosomes, and Others), Sample Type (Blood Sample Based, Urine Sample Based, Saliva & Other Tissue Fluid Sample-Based, Fecal Based Sampling, and Others), Analytical Type (Molecular, Proteomics, and Histology/Imaging), Application Type (Cancer Applications and Non-Cancer Applications), Clinical Application (Routine Screening, Patient Work-Up, Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Others), Technology (Multi-Gene Parallel Analysis, and Single-Gene Analysis), End User (Hospitals, Reference Laboratories, Diagnostic Centers, Research Centers & Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributor, and Others)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, China, Japan, India ,South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, and Rest of Middle East and Africa

Market Players Covered

Thermo Fisher Scientific Inc., Illumina, Inc., BIOCEPT, INC., Bio-Rad Laboratories, Inc., Exact Science Corporation, Menarini Silicon Biosystems, Epic Sciences, NeoGenomics Laboratories, mdxhealth, F. Hoffmann-La Roche Ltd, QIAGEN, Oncocyte Corporation, Johnson & Johnson Services, Inc., PathAI, Fluxion Biosciences Inc., Guardant Health, Laboratory Corporation of America Holdings, ANGLE plc, Natera, Inc., Sysmex Inostics Inc., (Subsidiary of Sysmex Corporation), STRECK and Predicine among others

Market Definition

A liquid biopsy is a medical test that involves the analysis of various biomolecules, such as DNA, RNA, proteins, and other substances in a patient's blood or other bodily fluids, to diagnose and monitor various medical conditions, including cancer. Unlike traditional biopsies that involve the removal of tissue samples from the body, a liquid biopsy is non-invasive and can provide important diagnostic information without the need for surgery or other invasive procedures. Liquid biopsies are still in the early stages of development but hold promise for improving the detection and management of cancer and other diseases.

Global Liquid Biopsy Market Dynamics

This section deals with understanding the market drivers, advantages, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • Growing Demand for Non-Invasive Liquid Biopsy Technique

The escalating demand for non-invasive liquid biopsy stems from its transformative impact on cancer diagnostics and treatment monitoring. Over the past decade, invasive techniques for diagnosing and monitoring cancers are slowly being replaced by non-invasive methods such as liquid biopsy. Liquid biopsies consist of isolating tumor-derived entities such as circulating tumor cells, circulating tumor DNA, and tumor extracellular vesicles among others, present in the body fluids of patients with cancer, followed by an analysis of genomic and proteomic data contained within them. Thus, growing demand for non-invasive liquid biopsy technique is driving market growth.

  • Advancements in precision medicine due to liquid biopsy

Genetic clones that are differentially evolving over time and space cause cancer progression. In this environment, it is still difficult to identify the mechanisms underlying tumor evolution. However, there has been a significant advance in our understanding of cancer in recent years, along with a crucial technological advancement in highly sensitive molecular biology techniques that ushers in the beginning of the practice of precision medicine and more specifically, precision oncology. Enhancing cancer diagnosis and treatment is the primary goal of precision oncology. A variety of genomic and molecular analyses can be applied to tumor material to aid in the identification of known predictive markers to guide the selection of treatment, derive a molecular subtype classification that may enable estimation of the prognosis, and identify molecular discriminants of progression disease. Thus, advancements in precision medicine due to liquid biopsy are expected to drive the market's growth.

Liquid Biopsy Market

Opportunity

  • Integration of Artificial Intelligence (AI) and Machine Learning

Liquid biopsy-based approaches offer many new opportunities to measure molecular biomarkers for diagnosing, prognosis, and monitoring disease. Artificial Intelligence (AI), such as machine learning, and its ability to identify signatures of specific disease states in multiplexed data will be key to taking advantage of the new molecular information that microchip-based diagnostics can extract.

Researchers in the field of liquid biopsy are developing technologies to measure sparse molecular biomarkers shed from inaccessible tissue in easily sampled bodily fluids, such as urine, blood, saliva, sweat, feces, and tears. The last decade has seen great progress in this field, and there is a growing list of circulating indicators rare: circulating cells, microvesicles, nucleic acids, proteins, and metabolites that can be detected. Machine learning encompasses a set of computational techniques widely applied in many fields to reduce large numbers of measurements into lower-dimensional outputs that are more useful. Thus, the integration of AI and machine learning is expected to act as an opportunity for the growth of the market.

Challenges/Restraints

  • High Cost of Liquid Biopsy Test

The liquid biopsy is severely constrained by the high cost. While liquid biopsy tests show promise for non-invasive illness detection and monitoring, including cancer, there are cost-related obstacles that may prevent their widespread use. The necessity for specialized tools and technologies is one of the biggest economic obstacles. Costly tools, including digital PCR machines, NGS platforms, and automated sample processing systems, are frequently needed for liquid biopsy studies. Smaller healthcare facilities with tighter budgets may find it difficult to afford the initial investment and ongoing maintenance costs connected with these technologies, which limits their capacity to provide liquid biopsy tests to patients. The costs of the reagents and consumables used in liquid biopsy testing might also add to the overall expense in addition to equipment expenditures. Especially when carried out on a big scale, DNA extraction kits, sequencing kits, and other lab materials can add up quickly. The average rate of liquid biopsy tests globally starts from USD 30.54 to USD 3,054.33. Thus, the high cost of liquid biopsy tests is expected to restrain the market's growth.

  • Lack of Skilled Professionals Performing Liquid Biopsy

The field of liquid biopsy is still relatively new and rapidly evolving, and there may be a shortage of skilled professionals who are trained and experienced in performing liquid biopsy tests. Liquid biopsy involves complex molecular techniques and analysis of genetic mutations, alterations, and other biomarkers in blood samples. Performing liquid biopsy requires specialized knowledge and expertise in molecular biology, genetics, and oncology, as well as proficiency in handling and processing blood samples. Not all clinical laboratories or healthcare institutions may have the necessary resources, equipment, and expertise to perform liquid biopsy tests, leading to a shortage of skilled professionals in this field.

Keeping up with the latest research, guidelines, and best practices in liquid biopsy can be challenging and may require continuous education and training. However, there may be limited opportunities for healthcare professionals to receive formal training or education in liquid biopsy, leading to a lack of skilled professionals who are proficient in performing these tests. Thus, the lack of skilled professionals performing liquid biopsies is expected to challenge the market growth.

Recent Developments

  • In January 2022, QIAGEN announced its new Biotech Grants program winners, an initiative driven by the company's commitment to building strong partnerships with biotechnology and pharma businesses and helping them succeed in the market. This has helped the company in revenue growth
  • In January 2022, Exact Sciences Corporation announced the acquisition of Prevention Genetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing (HCT)

Global Liquid Biopsy Market Scope

Global liquid biopsy market is segmented into nine notable segments based on product, biomarker type, sample type, analytical type, application type, clinical application, technology, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Product

  • Instruments
  • Consumables & Accessories  
  • Services & Software

On the basis of product, the market is segmented into instruments, consumables & accessories, and services & software.

Biomarker Type

  • Circulating Tumor Cells (CTCS)
  • Circulating Cell-Free DNA (CFDNA)
  • Cell-Free RNA
  • Extracellular Vesicles
  • Exosomes
  • Others

On the basis of biomarker type, the market is segmented into Circulating Tumor Cells (CTCS), Circulating Cell-Free DNA (CFDNA), cell-free RNA, extracellular vesicles, exosomes, and others.

Sample Type

  • Blood Sample-Based
  • Urine Sample-Based
  • Saliva & Other Tissue Fluids Sample-Based
  • Fecal Sample Based
  • Others

On the basis of sample type, the market is segmented into blood sample based, urine sample based, saliva & other tissue fluid sample-based, fecal sample based, and others.

Analytical Type

  • Molecular
  • Proteomic
  • Histology/Imaging

On the basis of analytical type, the market is segmented into molecular, proteomics, and histology/imaging.

Application Type

  • Cancer Applications
  • Non-Cancer Applications

On the basis of application type, the market is segmented into cancer applications and non-cancer applications.

Clinical Application

  • Routine Screening
  • Patient Work-Up
  • Therapy Selection
  • Treatment Monitoring  
  • Recurrence Monitoring
  • Others

On the basis of clinical application, the market is segmented into routine screening, patient work-up, therapy selection, treatment monitoring, recurrence monitoring, and others.

Technology

  • Multi-Gene-Parallel Analysis
  • Single Gene Analysis

On the basis of technology, the market is segmented into multi-gene parallel analysis and single-gene analysis.

End User

  • Hospitals
  • Reference Laboratories
  • Diagnostics Centers
  • Research Centres And Academic Institutes
  • Others

On the basis of end user, the market is segmented into hospitals, reference laboratories, diagnostic centers, research centers & academic institutes, and others.

Distribution Channel

  • Direct Tender
  • Third Party Distributor
  • Others

On the basis of distribution channel, the market is segmented into direct tender, third party distributor, and others.

Liquid Biopsy Market

Global Liquid Biopsy Market Regional Analysis/Insights

The global liquid biopsy market is categorized into nine notable segments based on product, biomarker type, sample type, analytical type, application type, clinical application, technology, end user, and distribution channel.

The countries covered in this market report U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Belgium, Netherlands, Switzerland, Denmark, Sweden, Norway, Finland, rest of Europe, China, Japan, India, Australia, South Korea, New Zealand, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Taiwan, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Qatar, Kuwait, Oman, Bahrain, and rest of Middle East And Africa.

U.S. in North America is expected to dominate the market due to the high prevalence of chronic condition patients and geriatric population needing nurse calling systems support in the region and the rise in healthcare expenditure. Germany dominates Europe region due to strong presence of key players. China dominates Asia-Pacific region due to the mass production of liquid biopsy based products and increasing demand from emerging markets and expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Liquid Biopsy Market

Competitive Landscape and Global Liquid Biopsy Market Share Analysis

Global liquid biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, product type lifeline curve. The above data points provided are only related to the company’s focus on the market.

Some of the major players operating in the global liquid biopsy market are Thermo Fisher Scientific Inc., Illumina, Inc., BIOCEPT, INC., Bio-Rad Laboratories, Inc., Exact Science Corporation, Menarini Silicon Biosystems, Epic Sciences, NeoGenomics Laboratories, mdxhealth, F. Hoffmann-La Roche Ltd, QIAGEN, Oncocyte Corporation, Johnson & Johnson Services, Inc., PathAI, Fluxion Biosciences Inc., Guardant Health, Laboratory Corporation of America Holdings, ANGLE plc, Natera, Inc., Sysmex Inostics Inc., (Subsidiary of Sysmex Corporation), STRECK and Predicine & among others.


SKU-

TABLE 1 WAYS IN WHICH LIQUID BIOPSY HAS ADVANCED PRECISION MEDICINE

TABLE 2 GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 3 GLOBAL CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 4 GLOBAL CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 5 GLOBAL CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 6 GLOBAL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 7 GLOBAL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 8 GLOBAL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 9 GLOBAL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 10 GLOBAL ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 11 GLOBAL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 12 GLOBAL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 13 GLOBAL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 14 GLOBAL SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 15 GLOBAL SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 16 GLOBAL LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 17 GLOBAL CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 18 GLOBAL CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 19 GLOBAL CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 20 GLOBAL CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 21 GLOBAL CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 22 GLOBAL CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 23 GLOBAL EXOSOMES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 24 GLOBAL EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 25 GLOBAL EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 26 GLOBAL EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 27 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 28 GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 29 GLOBAL BLOOD SAMPLE-BASED IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 30 GLOBAL URINE SAMPLE-BASED IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 31 GLOBAL SALIVA & OTHER TISSUE FLUIDS SAMPLE-BASED IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 32 GLOBAL FECAL SAMPLE BASED IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 33 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 34 GLOBAL LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 35 GLOBAL MOLECULAR IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 36 GLOBAL MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 37 GLOBAL PROTEOMIC IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 38 GLOBAL PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 39 GLOBAL HISTOLOGY/IMAGING IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 40 GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 41 GLOBAL CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 42 GLOBAL CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 43 GLOBAL BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 44 GLOBAL NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 45 GLOBAL NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 46 GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 47 GLOBAL ROUTINE SCREENING IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 48 GLOBAL THERAPY SELECTION IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 49 GLOBAL TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 50 GLOBAL TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 51 GLOBAL RECURRENCE MONITORING IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 52 GLOBAL PATIENT WORK-UP IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 53 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 54 GLOBAL LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 55 GLOBAL MULTI-GENE-PARALLEL ANALYSIS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 56 GLOBAL SINGLE GENE ANALYSIS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 57 GLOBAL LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 58 GLOBAL HOSPITALS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 59 GLOBAL REFERENCE LABORATORIES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 60 GLOBAL DIAGNOSTICS CENTERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 61 GLOBAL RESEARCH CENTRES AND ACADEMIC INSTITUTES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 62 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 63 GLOBAL LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 64 GLOBAL DIRECT TENDER IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 65 GLOBAL THIRD PARTY DISTRIBUTOR IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 66 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 67 GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 68 NORTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 69 NORTH AMERICA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 70 NORTH AMERICA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 71 NORTH AMERICA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 72 NORTH AMERICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 73 NORTH AMERICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 74 NORTH AMERICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 75 NORTH AMERICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 76 NORTH AMERICA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 77 NORTH AMERICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 78 NORTH AMERICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 79 NORTH AMERICA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 80 NORTH AMERICA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 81 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 82 NORTH AMERICA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 83 NORTH AMERICA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 84 NORTH AMERICA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 85 NORTH AMERICA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 86 NORTH AMERICA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 87 NORTH AMERICA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 88 NORTH AMERICA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 89 NORTH AMERICA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 90 NORTH AMERICA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 91 NORTH AMERICA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 92 NORTH AMERICA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 93 NORTH AMERICA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 94 NORTH AMERICA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 95 NORTH AMERICA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 96 NORTH AMERICA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 97 NORTH AMERICA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 98 NORTH AMERICA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 99 U.S. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 100 U.S. CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 101 U.S. CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 102 U.S. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 103 U.S. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 104 U.S. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 105 U.S. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 106 U.S. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 107 U.S. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 108 U.S. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 109 U.S. ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 110 U.S. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 111 U.S. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 112 U.S. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 113 U.S. SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 114 U.S. LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 115 U.S. CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 116 U.S. CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 117 U.S. CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 118 U.S. EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 119 U.S. EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 120 U.S. LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 121 U.S. LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 122 U.S. MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 123 U.S. PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 124 U.S. LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 125 U.S. CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 126 U.S. BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 127 U.S. NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 128 U.S. LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 129 U.S. TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 130 U.S. LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 131 U.S. LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 132 U.S. LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 133 CANADA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 134 CANADA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 135 CANADA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 136 CANADA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 137 CANADA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 138 CANADA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 139 CANADA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 140 CANADA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 141 CANADA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 142 CANADA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 143 CANADA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 144 CANADA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 145 CANADA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 146 CANADA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 147 CANADA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 148 CANADA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 149 CANADA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 150 CANADA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 151 CANADA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 152 CANADA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 153 CANADA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 154 CANADA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 155 CANADA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 156 CANADA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 157 CANADA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 158 CANADA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 159 CANADA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 160 CANADA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 161 CANADA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 162 CANADA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 163 CANADA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 164 CANADA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 165 CANADA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 166 CANADA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 167 MEXICO LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 168 MEXICO CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 169 MEXICO CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 170 MEXICO LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 171 MEXICO TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 172 MEXICO TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 173 MEXICO TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 174 MEXICO COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 175 MEXICO COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 176 MEXICO COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 177 MEXICO ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 178 MEXICO INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 179 MEXICO INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 180 MEXICO INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 181 MEXICO SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 182 MEXICO LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 183 MEXICO CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 184 MEXICO CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 185 MEXICO CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 186 MEXICO EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 187 MEXICO EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 188 MEXICO LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 189 MEXICO LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 190 MEXICO MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 191 MEXICO PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 192 MEXICO LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 193 MEXICO CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 194 MEXICO BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 195 MEXICO NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 196 MEXICO LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 197 MEXICO TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 198 MEXICO LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 199 MEXICO LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 200 MEXICO LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 201 EUROPE LIQUID BIOPSY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 202 EUROPE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 203 EUROPE CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 204 EUROPE CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 205 EUROPE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 206 EUROPE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 207 EUROPE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 208 EUROPE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 209 EUROPE ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 210 EUROPE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 211 EUROPE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 212 EUROPE SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 213 EUROPE LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 214 EUROPE CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 215 EUROPE CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 216 EUROPE CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 217 EUROPE EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 218 EUROPE EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 219 EUROPE LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 220 EUROPE LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 221 EUROPE MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 222 EUROPE PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 223 EUROPE LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 224 EUROPE CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 225 EUROPE BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 226 EUROPE NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 227 EUROPE LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 228 EUROPE TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 229 EUROPE LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 230 EUROPE LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 231 EUROPE LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 232 GERMANY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 233 GERMANY CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 234 GERMANY CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 235 GERMANY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 236 GERMANY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 237 GERMANY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 238 GERMANY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 239 GERMANY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 240 GERMANY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 241 GERMANY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 242 GERMANY ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 243 GERMANY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 244 GERMANY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 245 GERMANY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 246 GERMANY SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 247 GERMANY LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 248 GERMANY CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 249 GERMANY CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 250 GERMANY CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 251 GERMANY EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 252 GERMANY EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 253 GERMANY LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 254 GERMANY LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 255 GERMANY MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 256 GERMANY PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 257 GERMANY LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 258 GERMANY CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 259 GERMANY BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 260 GERMANY NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 261 GERMANY LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 262 GERMANY TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 263 GERMANY LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 264 GERMANY LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 265 GERMANY LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 266 FRANCE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 267 FRANCE CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 268 FRANCE CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 269 FRANCE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 270 FRANCE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 271 FRANCE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 272 FRANCE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 273 FRANCE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 274 FRANCE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 275 FRANCE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 276 FRANCE ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 277 FRANCE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 278 FRANCE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 279 FRANCE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 280 FRANCE SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 281 FRANCE LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 282 FRANCE CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 283 FRANCE CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 284 FRANCE CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 285 FRANCE EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 286 FRANCE EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 287 FRANCE LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 288 FRANCE LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 289 FRANCE MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 290 FRANCE PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 291 FRANCE LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 292 FRANCE CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 293 FRANCE BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 294 FRANCE NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 295 FRANCE LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 296 FRANCE TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 297 FRANCE LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 298 FRANCE LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 299 FRANCE LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 300 U.K. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 301 U.K. CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 302 U.K. CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 303 U.K. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 304 U.K. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 305 U.K. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 306 U.K. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 307 U.K. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 308 U.K. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 309 U.K. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 310 U.K. ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 311 U.K. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 312 U.K. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 313 U.K. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 314 U.K. SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 315 U.K. LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 316 U.K. CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 317 U.K. CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 318 U.K. CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 319 U.K. EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 320 U.K. EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 321 U.K. LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 322 U.K. LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 323 U.K. MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 324 U.K. PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 325 U.K. LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 326 U.K. CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 327 U.K. BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 328 U.K. NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 329 U.K. LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 330 U.K. TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 331 U.K. LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 332 U.K. LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 333 U.K. LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 334 ITALY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 335 ITALY CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 336 ITALY CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 337 ITALY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 338 ITALY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 339 ITALY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 340 ITALY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 341 ITALY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 342 ITALY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 343 ITALY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 344 ITALY ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 345 ITALY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 346 ITALY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 347 ITALY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 348 ITALY SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 349 ITALY LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 350 ITALY CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 351 ITALY CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 352 ITALY CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 353 ITALY EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 354 ITALY EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 355 ITALY LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 356 ITALY LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 357 ITALY MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 358 ITALY PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 359 ITALY LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 360 ITALY CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 361 ITALY BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 362 ITALY NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 363 ITALY LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 364 ITALY TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 365 ITALY LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 366 ITALY LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 367 ITALY LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 368 SPAIN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 369 SPAIN CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 370 SPAIN CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 371 SPAIN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 372 SPAIN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 373 SPAIN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 374 SPAIN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 375 SPAIN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 376 SPAIN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 377 SPAIN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 378 SPAIN ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 379 SPAIN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 380 SPAIN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 381 SPAIN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 382 SPAIN SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 383 SPAIN LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 384 SPAIN CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 385 SPAIN CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 386 SPAIN CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 387 SPAIN EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 388 SPAIN EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 389 SPAIN LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 390 SPAIN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 391 SPAIN MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 392 SPAIN PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 393 SPAIN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 394 SPAIN CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 395 SPAIN BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 396 SPAIN NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 397 SPAIN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 398 SPAIN TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 399 SPAIN LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 400 SPAIN LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 401 SPAIN LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 402 RUSSIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 403 RUSSIA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 404 RUSSIA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 405 RUSSIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 406 RUSSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 407 RUSSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 408 RUSSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 409 RUSSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 410 RUSSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 411 RUSSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (ASP)

TABLE 412 RUSSIA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 413 RUSSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 414 RUSSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 415 RUSSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 416 RUSSIA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 417 RUSSIA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 418 RUSSIA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 419 RUSSIA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 420 RUSSIA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 421 RUSSIA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 422 RUSSIA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 423 RUSSIA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 424 RUSSIA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 425 RUSSIA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 426 RUSSIA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 427 RUSSIA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 428 RUSSIA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 429 RUSSIA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 430 RUSSIA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 431 RUSSIA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 432 RUSSIA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 433 RUSSIA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 434 RUSSIA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 435 RUSSIA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 436 TURKEY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 437 TURKEY CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 438 TURKEY CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 439 TURKEY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 440 TURKEY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 441 TURKEY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 442 TURKEY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 443 TURKEY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 444 TURKEY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 445 TURKEY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 446 TURKEY ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 447 TURKEY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 448 TURKEY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 449 TURKEY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 450 TURKEY SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 451 TURKEY LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 452 TURKEY CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 453 TURKEY CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 454 TURKEY CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 455 TURKEY EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 456 TURKEY EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 457 TURKEY LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 458 TURKEY LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 459 TURKEY MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 460 TURKEY PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 461 TURKEY LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 462 TURKEY CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 463 TURKEY BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 464 TURKEY NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 465 TURKEY LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 466 TURKEY TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 467 TURKEY LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 468 TURKEY LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 469 TURKEY LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 470 BELGIUM LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 471 BELGIUM CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 472 BELGIUM CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 473 BELGIUM LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 474 BELGIUM TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 475 BELGIUM TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 476 BELGIUM TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 477 BELGIUM COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 478 BELGIUM COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 479 BELGIUM COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 480 BELGIUM ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 481 BELGIUM INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 482 BELGIUM INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 483 BELGIUM INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 484 BELGIUM SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 485 BELGIUM LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 486 BELGIUM CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 487 BELGIUM CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 488 BELGIUM CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 489 BELGIUM EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 490 BELGIUM EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 491 BELGIUM LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 492 BELGIUM LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 493 BELGIUM MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 494 BELGIUM PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 495 BELGIUM LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 496 BELGIUM CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 497 BELGIUM BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 498 BELGIUM NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 499 BELGIUM LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 500 BELGIUM TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 501 BELGIUM LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 502 BELGIUM LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 503 BELGIUM LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 504 NETHERLANDS LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 505 NETHERLANDS CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 506 NETHERLANDS CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 507 NETHERLANDS LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 508 NETHERLANDS TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 509 NETHERLANDS TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 510 NETHERLANDS TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 511 NETHERLANDS COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 512 NETHERLANDS COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 513 NETHERLANDS COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 514 NETHERLANDS ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 515 NETHERLANDS INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 516 NETHERLANDS INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 517 NETHERLANDS INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 518 NETHERLANDS SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 519 NETHERLANDS LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 520 NETHERLANDS CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 521 NETHERLANDS CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 522 NETHERLANDS CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 523 NETHERLANDS EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 524 NETHERLANDS EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 525 NETHERLANDS LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 526 NETHERLANDS LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 527 NETHERLANDS MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 528 NETHERLANDS PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 529 NETHERLANDS LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 530 NETHERLANDS CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 531 NETHERLANDS BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 532 NETHERLANDS NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 533 NETHERLANDS LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 534 NETHERLANDS TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 535 NETHERLANDS LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 536 NETHERLANDS LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 537 NETHERLANDS LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 538 SWITZERLAND LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 539 SWITZERLAND CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 540 SWITZERLAND CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 541 SWITZERLAND LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 542 SWITZERLAND TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 543 SWITZERLAND TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 544 SWITZERLAND TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 545 SWITZERLAND COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 546 SWITZERLAND COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 547 SWITZERLAND COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 548 SWITZERLAND ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 549 SWITZERLAND INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 550 SWITZERLAND INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 551 SWITZERLAND INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 552 SWITZERLAND SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 553 SWITZERLAND LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 554 SWITZERLAND CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 555 SWITZERLAND CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 556 SWITZERLAND CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 557 SWITZERLAND EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 558 SWITZERLAND EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 559 SWITZERLAND LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 560 SWITZERLAND LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 561 SWITZERLAND MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 562 SWITZERLAND PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 563 SWITZERLAND LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 564 SWITZERLAND CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 565 SWITZERLAND BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 566 SWITZERLAND NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 567 SWITZERLAND LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 568 SWITZERLAND TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 569 SWITZERLAND LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 570 SWITZERLAND LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 571 SWITZERLAND LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 572 REST OF EUROPE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 573 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 574 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 575 ASIA-PACIFIC CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 576 ASIA-PACIFIC CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 577 ASIA-PACIFIC TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 578 ASIA-PACIFIC TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 579 ASIA-PACIFIC COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 580 ASIA-PACIFIC COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 581 ASIA-PACIFIC ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 582 ASIA-PACIFIC INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 583 ASIA-PACIFIC INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 584 ASIA-PACIFIC SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 585 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 586 ASIA-PACIFIC CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 587 ASIA-PACIFIC CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 588 ASIA-PACIFIC CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 589 ASIA-PACIFIC EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 590 ASIA-PACIFIC EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 591 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 592 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 593 ASIA-PACIFIC MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 594 ASIA-PACIFIC PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 595 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 596 ASIA-PACIFIC CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 597 ASIA-PACIFIC BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 598 ASIA-PACIFIC NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 599 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 600 ASIA-PACIFIC TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 601 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 602 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 603 ASIA-PACIFIC LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 604 JAPAN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 605 JAPAN CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 606 JAPAN CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 607 JAPAN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 608 JAPAN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 609 JAPAN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 610 JAPAN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 611 JAPAN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 612 JAPAN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 613 JAPAN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 614 JAPAN ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 615 JAPAN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 616 JAPAN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 617 JAPAN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 618 JAPAN SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 619 JAPAN LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 620 JAPAN CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 621 JAPAN CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 622 JAPAN CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 623 JAPAN EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 624 JAPAN EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 625 JAPAN LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 626 JAPAN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 627 JAPAN MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 628 JAPAN PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 629 JAPAN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 630 JAPAN CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 631 JAPAN BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 632 JAPAN NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 633 JAPAN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 634 JAPAN TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 635 JAPAN LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 636 JAPAN LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 637 JAPAN LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 638 CHINA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 639 CHINA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 640 CHINA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 641 CHINA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 642 CHINA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 643 CHINA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 644 CHINA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 645 CHINA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 646 CHINA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 647 CHINA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 648 CHINA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 649 CHINA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 650 CHINA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 651 CHINA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 652 CHINA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 653 CHINA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 654 CHINA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 655 CHINA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 656 CHINA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 657 CHINA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 658 CHINA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 659 CHINA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 660 CHINA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 661 CHINA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 662 CHINA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 663 CHINA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 664 CHINA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 665 CHINA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 666 CHINA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 667 CHINA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 668 CHINA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 669 CHINA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 670 CHINA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 671 CHINA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 672 SOUTH KOREA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 673 SOUTH KOREA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 674 SOUTH KOREA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 675 SOUTH KOREA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 676 SOUTH KOREA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 677 SOUTH KOREA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 678 SOUTH KOREA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 679 SOUTH KOREA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 680 SOUTH KOREA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 681 SOUTH KOREA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 682 SOUTH KOREA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 683 SOUTH KOREA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 684 SOUTH KOREA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 685 SOUTH KOREA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 686 SOUTH KOREA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 687 SOUTH KOREA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 688 SOUTH KOREA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 689 SOUTH KOREA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 690 SOUTH KOREA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 691 SOUTH KOREA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 692 SOUTH KOREA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 693 SOUTH KOREA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 694 SOUTH KOREA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 695 SOUTH KOREA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 696 SOUTH KOREA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 697 SOUTH KOREA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 698 SOUTH KOREA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 699 SOUTH KOREA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 700 SOUTH KOREA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 701 SOUTH KOREA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 702 SOUTH KOREA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 703 SOUTH KOREA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 704 SOUTH KOREA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 705 SOUTH KOREA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 706 INDIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 707 INDIA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 708 INDIA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 709 INDIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 710 INDIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 711 INDIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 712 INDIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 713 INDIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 714 INDIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 715 INDIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 716 INDIA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 717 INDIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 718 INDIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 719 INDIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 720 INDIA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 721 INDIA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 722 INDIA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 723 INDIA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 724 INDIA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 725 INDIA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 726 INDIA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 727 INDIA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 728 INDIA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 729 INDIA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 730 INDIA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 731 INDIA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 732 INDIA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 733 INDIA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 734 INDIA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 735 INDIA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 736 INDIA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 737 INDIA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 738 INDIA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 739 INDIA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 740 AUSTRALIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 741 AUSTRALIA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 742 AUSTRALIA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 743 AUSTRALIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 744 AUSTRALIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 745 AUSTRALIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 746 AUSTRALIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 747 AUSTRALIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 748 AUSTRALIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 749 AUSTRALIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 750 AUSTRALIA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 751 AUSTRALIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 752 AUSTRALIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 753 AUSTRALIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 754 AUSTRALIA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 755 AUSTRALIA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 756 AUSTRALIA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 757 AUSTRALIA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 758 AUSTRALIA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 759 AUSTRALIA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 760 AUSTRALIA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 761 AUSTRALIA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 762 AUSTRALIA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 763 AUSTRALIA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 764 AUSTRALIA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 765 AUSTRALIA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 766 AUSTRALIA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 767 AUSTRALIA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 768 AUSTRALIA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 769 AUSTRALIA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 770 AUSTRALIA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 771 AUSTRALIA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 772 AUSTRALIA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 773 AUSTRALIA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 774 SINGAPORE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 775 SINGAPORE CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 776 SINGAPORE CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 777 SINGAPORE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 778 SINGAPORE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 779 SINGAPORE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 780 SINGAPORE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 781 SINGAPORE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 782 SINGAPORE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 783 SINGAPORE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 784 SINGAPORE ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 785 SINGAPORE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 786 SINGAPORE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 787 SINGAPORE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 788 SINGAPORE SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 789 SINGAPORE LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 790 SINGAPORE CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 791 SINGAPORE CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 792 SINGAPORE CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 793 SINGAPORE EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 794 SINGAPORE EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 795 SINGAPORE LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 796 SINGAPORE LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 797 SINGAPORE MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 798 SINGAPORE PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 799 SINGAPORE LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 800 SINGAPORE CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 801 SINGAPORE BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 802 SINGAPORE NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 803 SINGAPORE LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 804 SINGAPORE TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 805 SINGAPORE LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 806 SINGAPORE LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 807 SINGAPORE LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 808 THAILAND LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 809 THAILAND CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 810 THAILAND CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 811 THAILAND LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 812 THAILAND TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 813 THAILAND TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 814 THAILAND TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 815 THAILAND COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 816 THAILAND COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 817 THAILAND COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 818 THAILAND ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 819 THAILAND INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 820 THAILAND INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 821 THAILAND INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 822 THAILAND SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 823 THAILAND LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 824 THAILAND CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 825 THAILAND CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 826 THAILAND CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 827 THAILAND EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 828 THAILAND EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 829 THAILAND LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 830 THAILAND LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 831 THAILAND MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 832 THAILAND PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 833 THAILAND LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 834 THAILAND CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 835 THAILAND BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 836 THAILAND NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 837 THAILAND LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 838 THAILAND TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 839 THAILAND LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 840 THAILAND LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 841 THAILAND LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 842 MALAYSIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 843 MALAYSIA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 844 MALAYSIA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 845 MALAYSIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 846 MALAYSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 847 MALAYSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 848 MALAYSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 849 MALAYSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 850 MALAYSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 851 MALAYSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 852 MALAYSIA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 853 MALAYSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 854 MALAYSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 855 MALAYSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 856 MALAYSIA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 857 MALAYSIA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 858 MALAYSIA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 859 MALAYSIA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 860 MALAYSIA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 861 MALAYSIA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 862 MALAYSIA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 863 MALAYSIA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 864 MALAYSIA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 865 MALAYSIA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 866 MALAYSIA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 867 MALAYSIA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 868 MALAYSIA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 869 MALAYSIA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 870 MALAYSIA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 871 MALAYSIA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 872 MALAYSIA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 873 MALAYSIA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 874 MALAYSIA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 875 MALAYSIA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 876 INDONESIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 877 INDONESIA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 878 INDONESIA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 879 INDONESIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 880 INDONESIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 881 INDONESIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 882 INDONESIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 883 INDONESIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 884 INDONESIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 885 INDONESIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 886 INDONESIA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 887 INDONESIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 888 INDONESIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 889 INDONESIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 890 INDONESIA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 891 INDONESIA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 892 INDONESIA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 893 INDONESIA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 894 INDONESIA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 895 INDONESIA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 896 INDONESIA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 897 INDONESIA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 898 INDONESIA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 899 INDONESIA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 900 INDONESIA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 901 INDONESIA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 902 INDONESIA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 903 INDONESIA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 904 INDONESIA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 905 INDONESIA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 906 INDONESIA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 907 INDONESIA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 908 INDONESIA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 909 INDONESIA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 910 PHILIPPINES LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 911 PHILIPPINES CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 912 PHILIPPINES CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 913 PHILIPPINES LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 914 PHILIPPINES TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 915 PHILIPPINES TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 916 PHILIPPINES TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 917 PHILIPPINES COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 918 PHILIPPINES COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 919 PHILIPPINES COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 920 PHILIPPINES ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 921 PHILIPPINES INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 922 PHILIPPINES INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 923 PHILIPPINES INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 924 PHILIPPINES SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 925 PHILIPPINES LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 926 PHILIPPINES CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 927 PHILIPPINES CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 928 PHILIPPINES CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 929 PHILIPPINES EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 930 PHILIPPINES EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 931 PHILIPPINES LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 932 PHILIPPINES LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 933 PHILIPPINES MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 934 PHILIPPINES PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 935 PHILIPPINES LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 936 PHILIPPINES CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 937 PHILIPPINES BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 938 PHILIPPINES NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 939 PHILIPPINES LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 940 PHILIPPINES TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 941 PHILIPPINES LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 942 PHILIPPINES LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 943 PHILIPPINES LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 944 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 945 SOUTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 946 SOUTH AMERICA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 947 SOUTH AMERICA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 948 SOUTH AMERICA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 949 SOUTH AMERICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 950 SOUTH AMERICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 951 SOUTH AMERICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 952 SOUTH AMERICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 953 SOUTH AMERICA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 954 SOUTH AMERICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 955 SOUTH AMERICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 956 SOUTH AMERICA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 957 SOUTH AMERICA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 958 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 959 SOUTH AMERICA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 960 SOUTH AMERICA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 961 SOUTH AMERICA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 962 SOUTH AMERICA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 963 SOUTH AMERICA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 964 SOUTH AMERICA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 965 SOUTH AMERICA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 966 SOUTH AMERICA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 967 SOUTH AMERICA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 968 SOUTH AMERICA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 969 SOUTH AMERICA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 970 SOUTH AMERICA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 971 SOUTH AMERICA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 972 SOUTH AMERICA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 973 SOUTH AMERICA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 974 SOUTH AMERICA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 975 SOUTH AMERICA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 976 BRAZIL LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 977 BRAZIL CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 978 BRAZIL CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 979 BRAZIL LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 980 BRAZIL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 981 BRAZIL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 982 BRAZIL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 983 BRAZIL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 984 BRAZIL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 985 BRAZIL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 986 BRAZIL ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 987 BRAZIL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 988 BRAZIL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 989 BRAZIL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 990 BRAZIL SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 991 BRAZIL LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 992 BRAZIL CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 993 BRAZIL CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 994 BRAZIL CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 995 BRAZIL EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 996 BRAZIL EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 997 BRAZIL LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 998 BRAZIL LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 999 BRAZIL MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1000 BRAZIL PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1001 BRAZIL LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1002 BRAZIL CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1003 BRAZIL BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1004 BRAZIL NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1005 BRAZIL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1006 BRAZIL TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1007 BRAZIL LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 1008 BRAZIL LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 1009 BRAZIL LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 1010 ARGENTINA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1011 ARGENTINA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1012 ARGENTINA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1013 ARGENTINA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1014 ARGENTINA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1015 ARGENTINA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1016 ARGENTINA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1017 ARGENTINA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1018 ARGENTINA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1019 ARGENTINA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1020 ARGENTINA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1021 ARGENTINA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1022 ARGENTINA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1023 ARGENTINA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1024 ARGENTINA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1025 ARGENTINA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 1026 ARGENTINA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1027 ARGENTINA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1028 ARGENTINA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1029 ARGENTINA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1030 ARGENTINA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1031 ARGENTINA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 1032 ARGENTINA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1033 ARGENTINA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1034 ARGENTINA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1035 ARGENTINA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1036 ARGENTINA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1037 ARGENTINA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1038 ARGENTINA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1039 ARGENTINA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1040 ARGENTINA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1041 ARGENTINA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 1042 ARGENTINA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 1043 ARGENTINA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 1044 REST OF SOUTH AMERICA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1045 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 1046 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1047 MIDDLE EAST AND AFRICA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1048 MIDDLE EAST AND AFRICA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1049 MIDDLE EAST AND AFRICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1050 MIDDLE EAST AND AFRICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1051 MIDDLE EAST AND AFRICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1052 MIDDLE EAST AND AFRICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1053 MIDDLE EAST AND AFRICA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1054 MIDDLE EAST AND AFRICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1055 MIDDLE EAST AND AFRICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1056 MIDDLE EAST AND AFRICA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1057 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 1058 MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1059 MIDDLE EAST AND AFRICA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1060 MIDDLE EAST AND AFRICA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1061 MIDDLE EAST AND AFRICA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1062 MIDDLE EAST AND AFRICA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1063 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 1064 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1065 MIDDLE EAST AND AFRICA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1066 MIDDLE EAST AND AFRICA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1067 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1068 MIDDLE EAST AND AFRICA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1069 MIDDLE EAST AND AFRICA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1070 MIDDLE EAST AND AFRICA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1071 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1072 MIDDLE EAST AND AFRICA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1073 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 1074 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 1075 MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 1076 SOUTH AFRICA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1077 SOUTH AFRICA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1078 SOUTH AFRICA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1079 SOUTH AFRICA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1080 SOUTH AFRICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1081 SOUTH AFRICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1082 SOUTH AFRICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1083 SOUTH AFRICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1084 SOUTH AFRICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1085 SOUTH AFRICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1086 SOUTH AFRICA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1087 SOUTH AFRICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1088 SOUTH AFRICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1089 SOUTH AFRICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1090 SOUTH AFRICA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1091 SOUTH AFRICA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 1092 SOUTH AFRICA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1093 SOUTH AFRICA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1094 SOUTH AFRICA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1095 SOUTH AFRICA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1096 SOUTH AFRICA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1097 SOUTH AFRICA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 1098 SOUTH AFRICA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1099 SOUTH AFRICA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1100 SOUTH AFRICA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1101 SOUTH AFRICA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1102 SOUTH AFRICA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1103 SOUTH AFRICA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1104 SOUTH AFRICA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1105 SOUTH AFRICA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1106 SOUTH AFRICA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1107 SOUTH AFRICA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 1108 SOUTH AFRICA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 1109 SOUTH AFRICA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 1110 SAUDI ARABIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1111 SAUDI ARABIA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1112 SAUDI ARABIA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1113 SAUDI ARABIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1114 SAUDI ARABIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1115 SAUDI ARABIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1116 SAUDI ARABIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1117 SAUDI ARABIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1118 SAUDI ARABIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1119 SAUDI ARABIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1120 SAUDI ARABIA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1121 SAUDI ARABIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1122 SAUDI ARABIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1123 SAUDI ARABIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1124 SAUDI ARABIA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1125 SAUDI ARABIA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 1126 SAUDI ARABIA CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1127 SAUDI ARABIA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1128 SAUDI ARABIA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1129 SAUDI ARABIA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1130 SAUDI ARABIA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1131 SAUDI ARABIA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 1132 SAUDI ARABIA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1133 SAUDI ARABIA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1134 SAUDI ARABIA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1135 SAUDI ARABIA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1136 SAUDI ARABIA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1137 SAUDI ARABIA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1138 SAUDI ARABIA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1139 SAUDI ARABIA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1140 SAUDI ARABIA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1141 SAUDI ARABIA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 1142 SAUDI ARABIA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 1143 SAUDI ARABIA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 1144 U.A.E. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1145 U.A.E. CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1146 U.A.E. CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1147 U.A.E. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1148 U.A.E. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1149 U.A.E. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1150 U.A.E. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1151 U.A.E. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1152 U.A.E. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1153 U.A.E. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1154 U.A.E. ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1155 U.A.E. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1156 U.A.E. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1157 U.A.E. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1158 U.A.E. SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1159 U.A.E. LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 1160 U.A.E. CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1161 U.A.E. CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1162 U.A.E. CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1163 U.A.E. EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1164 U.A.E. EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1165 U.A.E. LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 1166 U.A.E. LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1167 U.A.E. MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1168 U.A.E. PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1169 U.A.E. LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1170 U.A.E. CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1171 U.A.E. BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1172 U.A.E. NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1173 U.A.E. LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1174 U.A.E. TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1175 U.A.E. LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 1176 U.A.E. LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 1177 U.A.E. LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 1178 EGYPT LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1179 EGYPT CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1180 EGYPT CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1181 EGYPT LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1182 EGYPT TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1183 EGYPT TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1184 EGYPT TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1185 EGYPT COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1186 EGYPT COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1187 EGYPT COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1188 EGYPT ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1189 EGYPT INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1190 EGYPT INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1191 EGYPT INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1192 EGYPT SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1193 EGYPT LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 1194 EGYPT CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1195 EGYPT CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1196 EGYPT CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1197 EGYPT EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1198 EGYPT EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1199 EGYPT LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 1200 EGYPT LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1201 EGYPT MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1202 EGYPT PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1203 EGYPT LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1204 EGYPT CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1205 EGYPT BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1206 EGYPT NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1207 EGYPT LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1208 EGYPT TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1209 EGYPT LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 1210 EGYPT LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 1211 EGYPT LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 1212 ISRAEL LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1213 ISRAEL CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1214 ISRAEL CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1215 ISRAEL LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1216 ISRAEL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1217 ISRAEL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1218 ISRAEL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1219 ISRAEL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1220 ISRAEL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1221 ISRAEL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 1222 ISRAEL ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1223 ISRAEL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1224 ISRAEL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)

TABLE 1225 ISRAEL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)

TABLE 1226 ISRAEL SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1227 ISRAEL LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)

TABLE 1228 ISRAEL CIRCULATING TUMOR CELLS (CTC’S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1229 ISRAEL CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1230 ISRAEL CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1231 ISRAEL EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1232 ISRAEL EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 1233 ISRAEL LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

TABLE 1234 ISRAEL LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1235 ISRAEL MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1236 ISRAEL PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)

TABLE 1237 ISRAEL LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1238 ISRAEL CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1239 ISRAEL BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1240 ISRAEL NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)

TABLE 1241 ISRAEL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1242 ISRAEL TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)

TABLE 1243 ISRAEL LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 1244 ISRAEL LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 1245 ISRAEL LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 1246 REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Liquid Biopsy Market will be worth USD 7,429.32 Million in the forecast period by 2031.
The Liquid Biopsy Market growth rate is 16.8% during the forecast period.
Growing Demand for Non-Invasive Liquid Biopsy Techniques and advancements in precision medicine due to liquid biopsy are the growth drivers of the Liquid Biopsy Market.
The product, biomarker type, sample type, analytical type, application type, clinical application, technology, end-user, and distribution channel are the factors on which the Liquid Biopsy Market research is based.
Major companies in the Liquid Biopsy Market are Thermo Fisher Scientific Inc., Illumina, Inc., BIOCEPT, INC., Bio-Rad Laboratories, Inc., Exact Science Corporation, Menarini Silicon Biosystems, Epic Sciences, NeoGenomics Laboratories, mdxhealth, F. Hoffmann-La Roche Ltd, QIAGEN, Oncocyte Corporation, Johnson & Johnson Services, Inc., PathAI, Fluxion Biosciences Inc., Guardant Health, Laboratory Corporation of America Holdings, ANGLE plc, Natera, Inc., Sysmex Inostics Inc., (Subsidiary of Sysmex Corporation), STRECK and Predicine.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials